A theranostic small-molecule prodrug conjugate for neuroendocrine prostate cancer

HIGHLIGHTS

  • who: Paulina Gonzalez et al. from the Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA have published the article: A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer, in the Journal: Pharmaceutics 2023, Pharmaceutics 2023,15, 15,481 x FOR PEER REVIEW of 29/Dec/2022
  • what: Based on the previously reported design of prodrug conjugates (T-SMPDCs) herein the authors report T-SMPDC tailored for targeted positron emission tomography (PET) imaging and chemotherapy of NEPC. The authors reason that small-molecule drug conjugates (SMDCs) can serve as an effective . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?